CDH1 and ovarian carcinoma: BRCA1/BRCA2, P53, the EMT phenotype (particularly E-Cadherin expression) and Dicer1 expression have independently been reported as a prognostic factors for chemotherapy resistance and survival of women with ovarian carcinoma [19–24].